
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$21.23
+$0.41 · +1.97%
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Regular session
$21.23
+$0.41 · +1.97%
Regular session · ET · Market data may be delayed.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Day range
Current $21.23
52-week range
Current $21.23
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
80
Undervalued
Sentiment
45
Mixed
Risk
50
Elevated Risk
Momentum
65
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Day range
Current $21.23
52-week range
Current $21.23
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 260.21M USD | 169.8M USD | 122.78M USD | 89.19M USD |
| Cost of goods sold | 89.27M USD | 66.92M USD | 52.81M USD | 46.39M USD |
| Gross profit | 170.94M USD | 102.88M USD | 69.97M USD | 42.79M USD |
| Research and development | 40.68M USD | 35.92M USD | 33.74M USD | 26.17M USD |
| Selling, general, and administrative | 142.23M USD | 110.61M USD | 102.23M USD | 88.97M USD |
| Operating expenses | 182.91M USD | 146.53M USD | 135.97M USD | 115.14M USD |
| Interest income | 5.31M USD | 805K USD | 5.78M USD | 2.2M USD |
| Interest expense | 2.53M USD | 4.51M USD | 4.71M USD | 4.2M USD |
| Depreciation and amortization | 5.49M USD | 4.8M USD | 4.45M USD | 4.33M USD |
| Operating income | −11.97M USD | −43.65M USD | −66M USD | −72.35M USD |
| Net income | −12.78M USD | −47.14M USD | −67.51M USD | −72.52M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$25.88
21.90% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI44.1M0.00%2.3T USD0.03%$382.05+0.66%
iShares Russell 2000 ETFIWM26.11M0.03%77.7B USD0.19%$279.26+0.61%
iShares Russell 2000 Growth ETFIWO9.19M0.07%14.04B USD0.24%$357.46+1.13%
First Trust Small Cap Growth AlphaDEX FundFYC6.85M0.51%1.77B USD0.70%$115.22+1.23%
Schwab U.S. Small-Cap ETFSCHA5.92M0.03%21.73B USD0.03%$32.845+0.57%
Vanguard Russell 2000 ETFVTWO5.03M0.03%18B USD0.06%$112.8+0.62%
State Street SPDR S&P Health Care Services ETFXHS3.49M1.71%204.53M USD0.35%$135.54+0.68%
Fidelity Enhanced Small Cap ETFFESM3.18M0.05%6.41B USD0.28%$45.52+0.60%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
iShares Russell 2000 Growth ETFIWO
First Trust Small Cap Growth AlphaDEX FundFYC
Schwab U.S. Small-Cap ETFSCHA
Vanguard Russell 2000 ETFVTWO
State Street SPDR S&P Health Care Services ETFXHS
Fidelity Enhanced Small Cap ETFFESMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.